Durgical
EN
Open the app

Cytosolic RNA and DNA sensors: RIG-I, MDA5, cGAS–STING

  • Molecule

Cells keep their DNA in the nucleus and their RNA well marked; viral RNA or DNA loose in the cytoplasm sets off type I interferon.

Updated

What it is

Besides the Toll-like receptors in endosomes, cells have sensors in the cytosol that detect nucleic acids out of place. RIG-I and MDA5 recognise viral RNA and signal through MAVS; cGAS detects DNA and makes a second messenger that activates STING. Both pathways end in type I interferon. When the sensors fire against the body's own nucleic acids, the result is an interferonopathy such as Aicardi–Goutières syndrome, SAVI or features of lupus.

Step by step

  1. Viral RNA with a 5′-triphosphate or long double strands appears in the cytosol.
  2. RIG-I (short dsRNA, 5′-triphosphate) or MDA5 (long dsRNA) binds it and activates MAVS on mitochondria.
  3. Double-stranded DNA in the cytosol (virus, bacteria, damaged mitochondria or nucleus) binds cGAS.
  4. cGAS makes cyclic GMP–AMP (cGAMP), which activates STING on the endoplasmic reticulum.
  5. MAVS and STING both activate TBK1, which phosphorylates IRF3; NF-κB is also switched on.
  6. IRF3 drives interferon-β; interferons induce an antiviral state in neighbouring cells and help NK and T cells.

Nucleic-acid sensors by location

SensorLocationLigandOutput
TLR3EndosomeDouble-stranded RNAType I interferon (via TRIF)
TLR7 and TLR8EndosomeSingle-stranded RNAType I interferon, inflammatory cytokines (via MyD88)
TLR9EndosomeUnmethylated CpG DNAType I interferon (plasmacytoid dendritic cells)
RIG-I and MDA5CytosolViral RNAType I interferon (via MAVS)
cGASCytosolDouble-stranded DNAcGAMP → STING → interferon-β
AIM2CytosolDouble-stranded DNAInflammasome → IL-1β, IL-18

Clinical notes

  • Aicardi–Goutières syndrome: variants in nucleases such as TREX1 or RNase H2 let self nucleic acids accumulate; early-onset encephalopathy with calcifications and chilblain-like skin lesions.
  • SAVI (STING-associated vasculopathy with onset in infancy): gain-of-function STING1 variants cause excess interferon-β, skin vasculopathy and lung disease.
  • Systemic lupus erythematosus shows an ‘interferon signature’; self nucleic acids in immune complexes stimulate TLR7/TLR9 in plasmacytoid dendritic cells.
  • JAK inhibitors, which block interferon signalling, are used in some interferonopathies.
  • Tumour DNA sensed by cGAS–STING in dendritic cells helps start anti-tumour T-cell responses.

Common traps

  • Cytosolic sensors duplicate the TLRs: TLR3, 7, 8 and 9 sample swallowed material in endosomes, while cytosolic sensors detect nucleic acids inside the infected cell itself.
  • cGAS is an RNA sensor: cGAS binds DNA and makes cGAMP for STING; RIG-I and MDA5 are the RNA sensors and signal through MAVS.
  • AIM2 makes interferon like cGAS: AIM2 also binds cytosolic DNA but forms an inflammasome, giving IL-1β and IL-18.
  • An interferonopathy means a hidden infection: it is sterile overproduction of type I interferon that can mimic a congenital viral infection.

Test yourself

Think of the answer, then tap the question to see it.

Why do cells need sensors in the cytosol when endosomal TLRs already detect viral nucleic acids?

Endosomal TLRs mainly sample material that immune cells swallow; cytosolic RIG-I, MDA5 and cGAS let any infected cell detect viral RNA or DNA replicating inside it and make interferon.

A virus cleaves MAVS. Which sensors are disabled, and which pathway still works?

RIG-I and MDA5, which signal through MAVS, are disabled; DNA sensing through cGAS–STING still works.

What kind of disease results from STING gain-of-function variants?

A type I interferonopathy: SAVI, with infant-onset skin vasculopathy and interstitial lung disease.

An infant has encephalopathy with brain calcifications and chilblain-like lesions, but no infection is found. What mechanism links these findings?

Aicardi–Goutières syndrome: a nuclease defect (TREX1, RNase H2) lets self nucleic acids build up, triggering cytosolic sensors and chronic type I interferon.

Add to my cards (4)

Connections

← All of immunology

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: Aicardi-Goutières syndrome (MedlinePlus Genetics, US National Library of Medicine, 2024); STING-associated vasculopathy with onset in infancy (MedlinePlus Genetics, US National Library of Medicine, 2024); Immune response to DNA and RNA: structural insights, molecular mechanisms, and therapeutic targeting (Molecular Biomedicine (PMC), 2026); Interferon signaling pathways in health and disease (Molecular Biomedicine (PMC), 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.